US › Healthcare

Lipella Pharmaceuticals Inc. Common Stock (LIPO)

US · Healthcare · Biotechnology

$0.000.00%

Last close · 2026-09-17

Key statistics

Market cap

$2,310

Forward P/E

0.0

P/B

0.00

Book value

$0.32

EPS (TTM)

$-2.26

52-week high

$0.64

52-week low

$0.00

50-day MA

$0.02

200-day MA

$0.11

Beta

1.57

Analyst view

Analysts rate Lipella Pharmaceuticals Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders

6.31%

Institutions

1.31%

Largest institutional holders

Fund	Stake
Tower Research Capital LLC	0.00%
Mccormack Advisors International	0.00%
Virtu Financial LLC	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lipella Pharmaceuticals Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.